Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine development using the simian immunodeficiency virus model for AIDS.

Stephen Norley1, Brigitte Beer, Doris Binninger-Schinzel

  • 1Robert Koch-Institut, Berlin, Germany. NorleyS@rki.de

Intervirology
|February 5, 2003
PubMed
Summary

Traditional simian immunodeficiency virus (SIV) vaccines in primates showed limited success. Current research focuses on genetic vaccines, including DNA and viral vectors, for enhanced efficacy against SIV infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning enhanced design and knowledge discovery for multi-junction photonic power converters.

Scientific reports·2025
Same author

Staphylococci in high resolution: Capturing diversity within the human nasal microbiota.

Cell reports·2025
Same author

Semantic enrichment of Pomeranian health study data using LOINC and WHO-FIC terminology mapping principles.

JAMIA open·2025
Same author

SARS-CoV-2 seroprevalence among people living with HIV in the German HIV-1 Seroconverter Cohort, 2020-2022.

BMC infectious diseases·2024
Same author

Body surface scan anthropometrics are associated with grip strength in the general population.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2024
Same author

Associations between 47 anthropometric markers derived from a body scanner and relative fat-free mass in a population-based study.

BMC public health·2024

Area of Science:

  • Veterinary immunology
  • Primate models for human disease

Background:

  • Simian immunodeficiency virus (SIV) infection in non-human primates serves as a model for human immunodeficiency virus (HIV) research.
  • Various vaccine strategies based on SIV have been tested in primate models.

Purpose of the Study:

  • To summarize the efficacy of different simian immunodeficiency virus (SIV) vaccine candidates tested in primate trials.
  • To evaluate the immune responses induced by these vaccines and their correlation with protection against SIV challenge.

Main Methods:

  • Immunization of rhesus macaques and African green monkeys (AGMs) with various SIV vaccine types.
  • Challenge with live SIV to assess vaccine efficacy and protection from infection or disease.
  • Analysis of immune responses, including neutralizing antibodies and cytotoxic T lymphocytes (CTLs).

Related Experiment Videos

Main Results:

  • Whole inactivated virus vaccines showed protection mediated by human cell proteins, not viral antigens.
  • Passive antibody transfer and SIV-specific CTL induction failed to prevent infection.
  • Live attenuated SIV induced sterilizing immunity in some cases, while other vaccine types showed limited or no protection in natural hosts (AGMs).

Conclusions:

  • Conventional SIV vaccine approaches are largely ineffective or unsuitable for human application.
  • Future vaccine development is shifting towards genetic vaccines, such as DNA and recombinant viral/bacterial vectors.